Mandate

Vinge advises in the acquisition of Veidekke’s property development operation in Norway and Sweden

Vinge has advised a consortium comprising Fredensborg AS, Fredensborg Bolig AS, Norwegian Property ASA and Union Real Estate Fund III Holding AS in its acquisition of Veidekke’s property development operation in Norway and Sweden

Veidekke has signed an agreement with a consortium comprising Fredensborg AS, Fredensborg Bolig AS, Norwegian Property ASA and Union Real Estate Fund III Holding AS concerning the consortium’s acquisition of Veidekke’s property development operation in Norway and Sweden against a payment of NOK 7.7 billion on a debt-free basis. Closing of the transaction is expected to take place in September 2020.

Vinge’s team consisted of, among others, Assur Badur, Frida Ställborn, Karolina Cohrs and Olof Löfvenberg (Real Property and Environment), Johan Winnerblad, Linda Sengul and Vilhelm Rondahl (M&A), Albert Wållgren, Ludvig Wettergren and Viktor Lennartsson (Financing), Lisa Hörnqvist (Commerical Agreements and IT), Ebba Svenburg (Employment) and the VDR-assistants Jessica Öijer and Carl Bruneheim.

Advokatfirmaet Thommessen has been the consortium’s lead legal counsel in the transaction.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025